SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
China Life Insurance Company Limited (CILJF) trades at a trailing P/E of 0.6, forward P/E of 0.8. Trailing earnings yield is 156.25%, forward earnings yield 131.58%. PEG 0.01 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.01); earnings yield beats bond yields (156.25%).
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 156.25% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 79/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CILJF
Valuation Multiples
P/E (TTM)0.6
Forward P/E0.8
PEG Ratio0.01
Forward PEG0.07
P/B Ratio0.00
P/S Ratio0.16
EV/EBITDA0.0
Per Share Data
EPS (TTM)$5.45
Forward EPS (Est.)$4.59
Book Value / Share$0.00
Revenue / Share$21.40
FCF / Share$0.00
Yields & Fair Value
Earnings Yield156.25%
Forward Earnings Yield131.58%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.66 |
$540.78B |
$19.13B |
3.5% |
| 2017 |
$1.13 |
$643.36B |
$32.25B |
5% |
| 2018 |
$0.40 |
$627.42B |
$11.4B |
1.8% |
| 2019 |
$2.05 |
$729.47B |
$58.29B |
8% |
| 2020 |
$1.78 |
$804.96B |
$50.26B |
6.2% |
| 2021 |
$1.80 |
$824.53B |
$50.77B |
6.2% |
| 2022 |
$1.14 |
$803.98B |
$32.08B |
4% |
| 2023 |
$0.75 |
$734.85B |
$21.11B |
2.9% |
| 2024 |
$3.78 |
$302.92B |
$106.94B |
35.3% |
| 2025 |
$5.45 |
$605.11B |
$154.08B |
25.5% |
